Evaluation of Intravenous Ascorbic Acid

Completed · Phase 1

Conditions studied: Safety and Pharmacokinetics of Intravenous Ascorbate

In brief

This Phase I study will be conducted in 2 parts to examine safety and pharmacokinetics of escalating doses of intravenous ascorbic acid (AA) first in healthy volunteers followed by evaluation in oncology subjects. The study will be conducted in the Program in Integrative Medicine Infusion Clinic at the University of Kansas Medical Center in conjunction with the Program in Integrative Medicine, Kansas Cancer Research Institute, Department of Pharmacy, Department of Medical Oncology, the Division of Surgical Oncology,and with consultants from the NIH, and FDA.

Key facts

Study ID
NCT01833351
Run by
University of Kansas Medical Center
People needed
34
Starts
2011-05-01
Expected to finish
2015-10-01
Last updated by the study team
2015-11-06

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.